Medicamen Organics Limited is engaged in developing, manufacturing, and distributing a broad range of pharmaceutical dosages including generic dosages in the form of Tablets,...
The new article elaborates further on special considerations associated with clinical investigations involving medical devices intended to be marketed and used in the UK,...
What stood out to me in yesterday’s Apple announcement wasn’t the headline, but the subtitle.
“Setting a new standard in privacy.”
For privacy to become one...
– Approval by Health Canada regulatory authority immediately clears the way for Pure Impact™ with PlyoPulse™ device launch and commercialization in Canada
– Canada Represents Another Substantial...
In the previous post, I discussed the various findings of the court in the present case regarding exhaustion, removal and replacement of the original mark...
The NMPA published the “Announcement on Standardizing the Classification of Medical Devices” on May 11, 2024. It revises the classification processes for devices, combination...
The article provides a general overview of the critical points associated with the registration procedures for healthcare products intended to be marketed and used...
